Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Ostroff

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biological Psychiatry|December 8, 2014
Successful Treatment of Tourette Syndrome With Electroconvulsive Therapy: A Case ReportJennifer N Guo, Jay S Kothari, James F Leckman, et al.
Epilepsia|February 14, 2007
Imaging onset and propagation of ECT-induced seizuresMiro Enev, Kelly A McNally, George Varghese, et al.
The Journal of Clinical Psychiatry|August 1, 2018
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric HospitalSamuel T Wilkinson, Rachel B Katz, Mesut Toprak, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 25, 2017
Ketamine as a Treatment for Adolescent Depression: A Case ReportJennifer B Dwyer, Chad Beyer, Samuel T Wilkinson, et al.
Focus (American Psychiatric Publishing)|April 16, 2025
Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for CliniciansSophie I Elliott, Rachel B Katz, Robert B Ostroff, et al.
Psychotherapy and Psychosomatics|May 11, 2017
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant DepressionSamuel T Wilkinson, DaShaun Wright, Madonna K Fasula, et al.
JAMA Psychiatry|May 11, 2022
Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical SettingSina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham, et al.
The American Journal of Psychiatry|March 4, 2003
Increased cortical GABA concentrations in depressed patients receiving ECTGerard Sanacora, Graeme F Mason, Douglas L Rothman, et al.
Contemporary Clinical Trials|March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocolSamuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Neuroimage|September 2, 2003
Selective frontal, parietal, and temporal networks in generalized seizuresHal Blumenfeld, Michael Westerveld, Robert B Ostroff, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biological Psychiatry|December 8, 2014
Successful Treatment of Tourette Syndrome With Electroconvulsive Therapy: A Case ReportJennifer N Guo, Jay S Kothari, James F Leckman, et al.
Epilepsia|February 14, 2007
Imaging onset and propagation of ECT-induced seizuresMiro Enev, Kelly A McNally, George Varghese, et al.
The Journal of Clinical Psychiatry|August 1, 2018
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric HospitalSamuel T Wilkinson, Rachel B Katz, Mesut Toprak, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 25, 2017
Ketamine as a Treatment for Adolescent Depression: A Case ReportJennifer B Dwyer, Chad Beyer, Samuel T Wilkinson, et al.
Focus (American Psychiatric Publishing)|April 16, 2025
Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for CliniciansSophie I Elliott, Rachel B Katz, Robert B Ostroff, et al.
Psychotherapy and Psychosomatics|May 11, 2017
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant DepressionSamuel T Wilkinson, DaShaun Wright, Madonna K Fasula, et al.
JAMA Psychiatry|May 11, 2022
Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical SettingSina Nikayin, Taeho Greg Rhee, Maria Elena Cunningham, et al.
The American Journal of Psychiatry|March 4, 2003
Increased cortical GABA concentrations in depressed patients receiving ECTGerard Sanacora, Graeme F Mason, Douglas L Rothman, et al.
Contemporary Clinical Trials|March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocolSamuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Neuroimage|September 2, 2003
Selective frontal, parietal, and temporal networks in generalized seizuresHal Blumenfeld, Michael Westerveld, Robert B Ostroff, et al.
Pageof 3